Connect with us

CWEB Business News

Danaher Corporation’s Analyst Meeting Review

Danaher Corporation (NYSE:DHR) hosted an in-person analyst meeting last week, providing investors a deeper dive into its portfolio evolution, DBS success stories, and the company’s longer-term targets.
The company announced its plans to separate its leading Water Quality test/treatment business and Product ID non-contact printing business into a standalone entity by Q4/23.
Analysts at RBC Capital expect the company can over-deliver and orchestrate the separation earlier than the initial target. According to the analysts, the upside in Cepheid COVID testing revenues in Q3/22 was nice to see, and the new long-term targets look achievable to them, especially given underlying market growth in biologics and Danaher’s share gains.

Follow us on Google news for more updates and News

Full Disclaimer

More in CWEB Business News



Get the most important news and analyses for Free.

Thank you for subscribing.

Something went wrong.